Subscribe
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes
Issues
2013
March 2013, Vol 3, No 2
March 2013, Vol 3, No 2
Understanding the National Practitioner Data Bank and What a Report Means to You and Your License
By
Jennifer Kirschenbaum, Esq
;
Kate Maguire, Esq
Read More ›
Introducing the Third Annual Conference of the Association for Value-Based Cancer Care
By
Burt Zweigenhaft, PhD, DLitt
AVBCC Summit Highlights
Read More ›
Payer Negotiations Regarding Specialty Pharmacy: Implications for Oncology Practices
By
Dawn Holcombe, MBA, FACMPE, ACHE
Practice Management
Health plans and oncology practices alike are evaluating the use of specialty pharmacy as a resource for the delivery of cancer drugs. Specialty pharmacy organizations are creating large divisions to manage oncology spending and to provide not only oral drugs but injectable and infused drugs as well.
Read More ›
Seeking Fine Surgical Cuts Under Sequestration, Not Blunt Hacking
By
Dawn Holcombe, MBA, FACMPE, ACHE
From the Editor
Read More ›
Time to Review Practice Policies: HIPAA Privacy and Security Regulations Released
By
Jayson Slotnik, JD, MPH
;
Ross D. Margulies
Health Policy
,
Practice Management
,
Practice Management
Read More ›
Second Circuit Okays Off-Label Promotion: What Will Be the Impact on Provider/Rep Interaction?
By
Sydney Abbott, JD
Since 2004, under the False Claims Act, whistleblowers have fueled numerous federal investigations into fraudulent claims for reimbursement from federal programs, such as Medicare, that violated the Food, Drug, & Cosmetic (FD&C) Act.
Read More ›
FDA-Approved Medications Used for the Treatment of Multiple Myeloma
ICD Codes
Read More ›
Think You Earn Too Much Money to Contribute to a Roth IRA? Guess Again
By
Lawrence B. Keller, CFP, CLU, ChFC, RHU, LUTCF
Financial Management
,
Practice Management
Read More ›
View the Latest Issue of OPM
Read Issue
Top Trending Articles
1.
Specialty Carve-Outs: What Are the Implications for Patients and Practices?
By
Dawn Holcombe, MBA, FACMPE, ACHE
2.
New Policies Regarding Intravenous Iron Replacement Are Creating Conundrum for Providers and Payers
By
Dawn Holcombe, MBA, FACMPE, ACHE
3.
2023 Spotlight: Amgen
Home
Issues
Latest Issue
Issue Archive
Special Issues
2022 Midyear Review: Non–Small-Cell Lung Cancer
2022 Oncology Biosimilar Guide to Patient Support Services
2022 Breast Cancer Guide to Patient Support Services
Browse By Topic
Practice Management
Financial Management
Reimbursement
Health Policy
Quality Care
ICD Codes
Survivorship
FDA Approvals, News & Updates
In the News
Guide to Patient Support Services
Index
Introduction
2023 Spotlight
Conference Correspondent
ASCO 2022 - Wrap Up
NSCLC IO 2022 - Midyear Review
SABCS 2021 Wrap-Up
Dual IO 2021 Year in Review
Web Exclusives
Web Exclusive Articles
Videos
Interview with the Innovators
Webinars
Rapid Reactions
In the News
Quick Quiz
Multiple Myeloma Monthly Minutes
Melanoma Monthly Minutes
Press Releases
Women's Health Monthly Minutes
Lung Cancer Monthly Minutes
Gastrointestinal Cancer Monthly Minutes